Forget Playing Outside: Big Pharma’s Solution To Childhood Obesity Is More Drugs

Big Pharma is willing to cash in on the newest cash crop in American healthcare: childhood obesity.

Monday’s new guidelines from the American Academy of Pediatrics (AAP), which address childhood obesity, were published by the AAP. They recommend that children take a combination of pills and surgery to achieve long-term weight loss.

Instead of telling the children to get out of their cars and not use their phones, give them some aggressive guidance Suggestions To combat the rising obesity epidemic among adolescents, it is recommended that children 12 and older with severe obesity take medication. As candidates for bariatric operation, obese teenagers aged 13 and over should be screened.

Teenagers considered The Centers for Disease Control and Prevention (CDC), considers someone obese if their body mass (BMI) is at or above the 95th per centile for children and teenagers of the same age and sex. According According to the CDC, almost 20 percent of children between 2 and 19 years old are considered obese.

The AAP recommendations reflect growing alarmism over the obesity epidemic, which is particularly surging among children — many of whom are raised as lifelong medical patients trapped by the habits of their parents and a processed diet. People with obesity are more likely to develop chronic diseases like diabetes or high blood pressure. The mental effects of excessive weight are especially dangerous for children, who are often bullied and teased.

Medications proposed to combat the crisis include Orlistat and semaglutide — which are already approved by the Food and Drug Administration for obesity treatment in children 12 and older — and metformin, which may be prescribed off-label. These medications come with their own problems and can lead to long-term failure if not managed properly.

Ozempic, a brand name form of semaglutide commonly used to treat Type 2 diabetics, offers patients a multitude of benefits. harmful side effects Include nausea, vomiting and abdominal pain.

Dr. Sudeep Singh is a Miami-based medical director for a concierge practice. Telled Last fall, The Cut found that approximately half of his patients who received the medicine had gastrointestinal side-effects. Dr. Tim Logemann, however, a specialist in cardiology and obesity in Wisconsin, touted Ozempic as doctors’ most effective medicine for weight loss.

“We love it,” Logemann spoke with The Federalist in an interview. “We use it every chance we get.”

Logemann, who treats obesity in adults, said that while he didn’t have a strong opinion on administering the medicine to minors, there’s a “sadness about it.” He explained that side effects do not necessarily mean that the medication is effective.

“It would be better if kids could eat good food and didn’t need this drug,” Logemann said. “It’s very sad we can’t keep kids safe from bad food.”

According to Nina Teicholz, a nutrition journalist Nina Teicholz, the FDA approved the drug for children who are experiencing weight loss within 18 days. This was based on one trial. She Labels the injections’ approval for obese adolescents as a textbook case of “pay to play,” Take the drug with you

*As an Amazon Associate I earn from qualifying purchases